Adjuvant chemotherapy decisions in clinical practice for early-stage node-negative, estrogen receptor-positive, HER2-negative breast cancer: Challenges and considerations

6Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Decisions regarding adjuvant chemotherapy for patients with estrogen receptor (ER)-positive, HER2-negative, lymph node-negative breast cancer have traditionally relied on clinical and pathologic parameters. However, the molecular heterogeneity and the complex tumor genome demand more sophisticated approaches to the problem. Several multigene-based assays have been developed to better prognosticate the risk of recurrence and death and predict benefit of therapy in this patient population. Oncologists are often faced with the challenge of incorporating these various complex genome-based biomarkers along with the traditional biomarkers in clinical decision-making. The NCCN Clinical Practice Guidelines in Oncology for Breast Cancer are helpful in providing a general recommendation. However, uncertainty remains in the absence of definitive data for various clinical scenarios. This case report describes a postmenopausal woman with stage I breast cancer that is low-grade and ER-rich, and has an intermediate Oncotype DX recurrence score of 28. Copyright © 2013 by the National Comprehensive Cancer Network. All rights reserved.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Nagaraj, G., & Ma, C. X. (2013). Adjuvant chemotherapy decisions in clinical practice for early-stage node-negative, estrogen receptor-positive, HER2-negative breast cancer: Challenges and considerations. JNCCN Journal of the National Comprehensive Cancer Network, 11(3), 246–251. https://doi.org/10.6004/jnccn.2013.0036

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

64%

Researcher 4

29%

Professor / Associate Prof. 1

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

53%

Agricultural and Biological Sciences 3

20%

Biochemistry, Genetics and Molecular Bi... 3

20%

Computer Science 1

7%

Save time finding and organizing research with Mendeley

Sign up for free